Repella Robert 4
4 · Vanda Pharmaceuticals Inc. · Filed Feb 19, 2013
Insider Transaction Report
Form 4
Repella Robert
SVP & Chief Commercial Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2013-02-14−15,000→ 45,000 total→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2013-02-14+15,000→ 15,000 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The restricted stock units vest in four equal annual installments beginning January 1, 2013, provided that Mr. Repella has remained in continuous service with the Issuer on each applicable vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the Restricted Stock Unit Agreement) that occurs on or after the day when the Restricted Stock Units vest.
- [F3]Not applicable.